Thirty-four clinical isolates of the family Enterobacteriaceae from the University of Texas M. D. Anderson Cancer Center appeared resistant to ticarcillin-potassium clavulanate in agar dilution and broth macrodilution tests. Among those isolates producing a single non-class I I-lactamase, resistance was due to production of high levels of TEM-1, SHV-1, or class IV enzymes. In five Escherichia coli isolates, production of low levels of PSE-1 was responsible for resistance which seemed due to rapid hydrolysis of ticarcillin rather than diminished susceptibility of PSE-1 to inhibition by potassium clavulanate. Comparisons of dilution and disk diffusion tests revealed major discrepancies, with 65% false susceptibility in the disk test. Revision of the interpretive criteria used for disk diffusion tests from ' 11 to < 18 mm for resistance is proposed to resolve these discrepancies until clinical data are obtained which can be used to determine which in vitro test is most predictive of therapeutic outcome. These new criteria would diminish false susceptibility without introducing false resistance.
Combinations containing a 1-lactamase inhibitor and an enzyme-labile drug have been shown to be highly effective both in vitro and in vivo against many P-lactamase-producing bacteria (2, 16) . Potassium clavulanate is a suicide inhibitor of many 3-lactamases and, in combination with ticarcillin, restores the activity of the latter against members of the family Enterobacteriaceae producing enzymes of essentially all Richmond and Sykes classes except class I, the chromosomal cephalosporinases (5, 10, 22) . However, in a recent survey of piperacillin-resistant members of the Enterobacteriaceae, a number of ticarcillin-potassium clavulanate (Timentin)-resistant strains were found among isolates recovered from patients at the University of Texas M. D. Anderson Cancer Center. Many of these organisms belonged to genera that characteristically produce the plasmid-mediated enzymes of Richmond and Sykes classes III and V that are usually highly susceptible to inhibition by potassium clavulanate. Thus, their resistance to ticarcillinpotassium clavulanate was unexpected.
Therefore, a study was designed to assess the mechanisms responsible for resistance to ticarcillin-potassium clavulanate in 34 clinical isolates of the Enterobacteriaceae. During the study, questions arose concerning the validity of results obtained in certain types of susceptibility tests with ticarcillin-potassium clavulanate, and these are addressed as well. multiple isolates from the same patient unless differences in ,-lactam susceptibility were noted. These 55 isolates included 26 Escherichia coli, 18 Klebsiella pneumoniae, 2 K. oxytoca, 8 Citrobacter spp., and 1 Serratia sp. Initial susceptibility tests were performed by a broth microdilution procedure in one laboratory (G.P.B.). All isolates were then sent to a second laboratory (C.C.S.) for retesting and determination of 1-lactamase content.
MATERIALS
Susceptibility tests. All susceptibility tests except agar dilution were performed by standard procedures (14, 15) . For all dilution procedures, the antibiotics, kindly provided by their respective manufacturers, were prepared on the day of use. Agar dilution tests were performed in Mueller-Hinton with an inoculum of 105 CFU per spot applied with a Steers replicator (21) . Broth macrodilution tests were performed in Mueller-Hinton (3-ml final volume) with an inoculum of 105 CFU/ml. The MIC was defined as the lowest concentration preventing growth after incubation for 18 h at 35°C. The MIC of ticarcillin-potassium clavulanate was determined with serial twofold dilutions of ticarcillin, each containing a constant concentration of 2 ,ug of potassium clavulanate per ml. MICs were interpreted according to the National Committee for Clinical Laboratory Standards guidelines, with -128 .ig of ticarcillin per ml indicative of resistance, 32 to 64 pLg/ml indicative of moderate susceptibility, and .16 xg/ml indicative of susceptibility (15) . Control strains were included in each run to monitor reproducibility, which was found to be + 1 dilution. Disk diffusion tests were performed with commercially prepared disks containing 75 ,ug of ticarcillin and 10 ,ug of potassium clavulanate. Interpretive criteria were zones of '11 mm for resistance, 12 to 14 mm for intermediate susceptibility, and .15 mm for susceptibility (5) . Antibiotic susceptibility profiles were determined for each isolate, using commercially prepared disks containing ticarcillin, piperacillin, cefoxitin, cephalothin, cefoperazone, cefamandole, cefotaxime, and ceftazidime.
Characterization of I-lactamases. For organisms producing P-lactamases constitutively, sonic extracts were prepared from overnight cultures in Mueller-Hinton broth. For organisms producing inducible ,-lactamases, sonic extracts were prepared following a 2-h induction by cefoxitin at one-fourth its MIC (18) . All sonic extracts were frozen at -70°C until tested. 3-Lactamases were characterized initially by determining their (i) pI in polyacrylamide gels (19) ; (ii) susceptibility to inhibition by cloxacillin and potassium clavulanate after focusing (19) ; (iii) ability to hydrolyze penicillin G, cephalothin, and nitrocefin; and (iv) inducibility by cefoxitin. These characteristics were then compared with those obtained with enzyme standards prepared from strains possessing well-characterized P-lactamases. These 
coli 7259), OXA-5 (E. coli J53-pMG54), OXA-6 (Pseudomonas aeruginosa PA038-pMG39), OXA-7 (E. coli 7181), OHIO-1 (E. coli C600:075), SHV-1 (E. coli J53 R1010), HMS-1 (E. coli J53.2-R997), PSE-1 (P. aeruginosa PU21-RPL11), PSE-2 (P. aeruginosa PU21-R151), PSE-3 (P. aeruginosa PU21-RMS149), PSE-4 (P. aeruginosa PU21-pMG19), and SAR-1 (E. coli J62.2-pUK657). Additional substrates were examined as necessary whenever these initial characteristics did not provide a definitive identification. For example, any enzyme appearing to be SHV-1 was tested for activity against ceftazidime and cefotaxime since SHV-1 and SHV-2 have the same pI but differ in their substrate profile (9) . Similarly, any enzyme appearing to be class IV was tested for its ability to hydrolyze cefotaxime and aztreonam since certain plasmid-mediated enzymes (e.g., OXA-7) have a similar pl but different substrate profiles. Very low levels of constitutively produced chromosomal enzyme present in most gram-negative bacteria were ignored for the purposes of this investigation.
13-Lactamase assays. Hydrolysis of cephalosporins and aztreonam was determined in UV spectrophotometric assays monitoring the Xmax associated with the P-lactam ring (18) . Hydrolysis of penicillins was determined in microiodometric and spectrophotometric assays (20, 24) . The amount of,-lactamase in sonic extracts was quantified with nitrocefin as a substrate. One unit of specific activity was defined as the amount of enzyme hydrolyzing 1 nmol of nitrocefin at pH 7.0 and 37°C per min per mg of protein in sonic extracts.
The susceptibility of P-lactamases to inhibition by potassium clavulanate was determined quantitatively by preincubating enzyme with various concentrations of inhibitor for 10 min. Nitrocefin (100 ,uM) was then added as the substrate, and residual enzyme activity was measured. The concentration of potassium clavulanate required to inhibit 50% of enzyme activity (150) was then determined by probit analysis.
Kinetic parameters were established for the enzyme in sonic extracts prepared from PSE-1-producing E. coli 45. Nitrocefin was used as the substrate, and potassium clavulanate and cloxacillin were used as inhibitors. Km and Vmax were determined from Lineweaver-Burk plots for various substrate concentrations. K, was determined from a secondary replot of slopes of Lineweaver-Burk plots for various inhibitor concentrations (4) . The enzyme in sonic extracts from E. coli 45 was concentrated by dialysis in membranes (PA10) retaining material of .10,000 molecular weight. It was then partially purified by molecular sieve chromatography (Sephadex G-75). Molecular weight was estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, using 7.5% polyacrylamide (25) .
RESULTS
Susceptibility tests. The susceptibility of the 55 piperacillin-resistant isolates to ticarcillin, potassium clavulanate, and ticarcillin-potassium clavulanate was determined in agar dilution tests. MICs for all isolates were >128 p.g of ticarcillin per ml and between 16 and 64 ,ug of potassium clavulanate per ml. The isolates fell into three groups based on susceptibility to ticarcillin-potassium clavulanate (the latter at a constant concentration of 2 ,ug/ml). Group 1 consisted of 34 resistant isolates (11 with MICs of 128 ,xg and 23 with MICs of >128 ,ug of ticarcillin per ml); group 2 consisted of 16 moderately susceptible isolates (MIC, 32 to 64 ,ug/ml); and group 3 consisted of 5 susceptible isolates (MIC, <16 ,ug/ml). Disk diffusion tests showed all group 3 and all but one group 2 isolates to be susceptible to ticarcillin-potassium clavulanate ( Table 1 ). The remaining group 2 isolate was of intermediate susceptibility. However, for group 1 isolates, only 2 (6%) had zones indicative of resistance, while 22 (65%) had zones indicative of susceptibility. The remaining 10 (27%) appeared to be of intermediate susceptibility. Mean zone sizes (mm) ± 1 standard deviation were 15.4 ± 2.7 for group 1, 19.2 ± 2.8 for group 2, and 22.8 ± 1.6 for group 3 isolates.
Since there was a great disparity between results of disk diffusion and agar dilution susceptibility tests, broth macrodilution tests were also performed on group 1 isolates. Results indicated that 30 of the 34 isolates were resistant, 3 were moderately susceptible, and 1 was susceptible to ticarcillin-potassium clavulanate. After raising the potassium clavulanate concentration in broth macrodilution tests from 2 to 5 ,ugIml, 21 of the 34 (62%) group 1 isolates still appeared resistant; 9 (26%) appeared moderately susceptible, and 4 (12%) appeared susceptible to ticarcillin-potassium clavulanate.
Types of enzymes responsible for ticarcillin-potassium clavulanate resistance. Each of the 34 group 1 isolates produced at least one ,-lactamase. From substrate and inhibitor profiles and pls, the identity of these enzymes could be determined (Table 2) . Thirteen isolates produced TEM-1 only, two produced SHV-1 only, and two produced TEM-1 plus SHV-1. These included 10 E. coli and 7 K. pneumoniae. Two isolates produced a chromosomal enzyme plus TEM-1. These included one Serratia sp. with an inducible class I enzyme and one Citrobacter freundii with only low constitutive levels of class I enzyme. Seven isolates produced only a chromosomal enzyme (Table 2 ). These included two K. oxytoca producing high constitutive levels of class IV en- zyme and five C. freundii producing high constitutive levels of class I enzyme. Five E. coli appeared to produce only PSE-1. Two K. pneumoniae produced both PSE-1 and SHV-1. One remaining E. coli produced TEM-1 plus a second enzyme with a pl of 5.15 which focused consistently between HMS-1 (pI 4.86) and PSE-4 (pl 5.19).
Quantity of enzyme and susceptibility to potassium clavulanate. Since all of the P-lactamases except the class I enzymes that were found in the group 1 isolates are purportedly susceptible to inhibition by potassium clavulanate, tests were performed to quantify the enzymes to see whether production of high levels of enzyme were responsible for the ticarcillin-potassium clavulanate resistance in these strains. Susceptibility of the enzymes to inhibition by potassium clavulanate was also determined for 22 group 1 isolates producing a single non-class I P-lactamase. For comparative purposes, 12 group 2 and 4 group 3 isolates producing only TEM-1 or SHV-1 were also included.
The relationship between quantity of TEM-1 or SHV-1 produced and susceptibility to ticarcillin-potassium clavulanate is shown in Table 3 . The mean quantity of TEM-1 or SHV-1 produced was highest for isolates in group 1, intermediate for isolates in group 2, and lowest for isolates in group 3. This direct association between enzyme quantity (Table 4) indicates the irreversible nature of the inhibition once saturating concentrations of the inhibitor are achieved. The apparent molecular weight of the enzyme in E. coli 45 was 31,500 by both Sephadex G-75 chromatography and sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
The results obtained in tests with E. coli 45 suggested that the ticarcillin-potassium clavulanate resistance in this strain was due to the rapid hydrolysis of ticarcillin by PSE-1 rather than to any lack of susceptibility of the enzyme for the inhibitor. Thus, MIC determinations were repeated with all five E. coli strains that appeared to produce PSE-1, using 5 ,ug of potassium clavulanate per ml to determine whether MICs of ticarcillin could be brought into the clinically achievable range with a higher concentration of inhibitor. With 5 ,ug of potassium clavulanate per ml, MICs of ticarcillin decreased to 16 to 64 ,ug/ml for the five isolates producing PSE-1.
DISCUSSION
The mechanisms responsible for resistance to ticarcillinpotassium clavulanate among clinical isolates of the Enterobacteriaceae that do not produce high levels of class I ,-lactamase have not been examined extensively. Clearly, such strains exist among E. coli and Klebsiella spp., although they are usually a small minority of total isolates examined (5, 8, 17, 22, 23) . Thus, the availability of a fairly large collection of ticarcillin-potassium clavulanate-resistant members of the Enterobacteriaceae presented the first opportunity to examine this aspect in detail.
The results of this study showed an inverse relationship between quantity of P-lactamase produced and susceptibility to ticarcillin-potassium clavulanate which has not been previously documented. Joly et al. (8) The role of PSE-1 in resistance to ticarcillin-potassium clavulanate among members of the Enterobacteriaceae has not been investigated previously. PSE-1 was once thought to be restricted to P. aeruginosa (12) . However, in 1982, Medeiros et al. described isolates of the Enterobacteriaceae that produced this enzyme (13) . Nevertheless, since PSE-1 is still most prevalent in P. aeruginosa and is only rarely found in members of the Enterobacteriaceae, all of the studies concerning the effects of potassium clavulanate on strains possessing this enzyme specifically have been performed in P. aeruginosa. Such studies have shown that MICs or MBCs of penicillins for P. aeruginosa with PSE-1 may be reduced by potassium clavulanate; however, they usually do not fall into the clinically achievable range (3, 6) .
The results obtained with E. coli 45 indicated that the enzyme responsible for ticarcillin-potassium clavulanate resistance in five isolates of E. coli was PSE-1. The identical pl and molecular weight, as well as the substrate profile and resistance to cloxacillin, clearly identified this enzyme as PSE-1 (12, 13) . PSE-1 has been shown to be susceptible to inhibition by potassium clavulanate in previous studies by Li et al. (11) , and it also appeared highly susceptible in a variety of tests in the current study. This susceptibility to potassium clavulanate was reflected by the ability of this inhibitor at higher concentrations to reduce the MIC of ticarcillin against the five E. coli producing PSE-1 to clinically achievable concentrations. Thus, for PSE-1-producing E. coli, it appears that rapid hydrolysis of ticarcillin by low levels of a potassium clavulanate-susceptible enzyme is responsible for the ticarcillin-potassium clavulanate resistance in these strains.
In addition to identifying mechanisms responsible for resistance to ticarcillin-potassium clavulanate, a major disagreement between results of dilution and diffusion susceptibility tests was also noted in this study. Many strains appearing to be resistant to ticarcillin-potassium clavulanate in agar and broth dilution susceptibility tests appeared to be susceptible in disk diffusion assays. The most likely explanation for this disparity was the difference in the concentration of potassium clavulanate in the two types of tests. Disks contained 10 ,ug of the inhibitor, while dilution tests were performed with only 2 ,ug/ml (5, 14, 15) . These fixed concentrations were derived from results of several studies indicating that (i) MICs were comparable whether 1, 2, or 4 jig of potassium clavulanate per ml was used in dilution tests; (ii) correlation was similar between MICs determined with ticarcillin plus 2 ,ug of potassium clavulanate per ml and zone sizes obtained with disks containing ticarcillin (75 ,ug) plus 10, 5, or 2.5 ,ug of potassium clavulanate; and (iii) levels in serum and tissue of 2 p.g of potassium clavulanate per ml were easily achieved and maintained for up to 2 h after standard doses of ticarcillin-potassium clavulanate were administered to humans (1, 5, 7) . However, even in these earlier studies, several problems were noted.
Fuchs et al. recommended the interpretive criteria for zone sizes currently used (5). However, they did note a high "very major" error rate (false susceptibility) with all disks regardless of their concentration of potassium clavulanate. In fact, for 17 nonstaphylococcal isolates with ticarcillinpotassium clavulanate MICs of >64 p.g/ml, only 8 (47%) gave zones indicative of resistance while 5 (29%) gave zones indicative of susceptibility. This 29% false sensitivity was smaller than the 65% rate observed in the current study. However, the current study was biased toward collecting isolates that were resistant to ticarcillin-potassium clavulanate. Thus, these differences may merely reflect the larger number of resistant strains analyzed here. They may also 
